Literature DB >> 25308981

Non-invasive Foetal ECG - a Comparable Alternative to the Doppler CTG?

J Reinhard1, F Louwen1.   

Abstract

This review discusses the alternative of using the non-invasive foetal ECG compared with the conventionally used Doppler CTG. Non-invasive abdominal electrocardiograms (ECG) have been approved for clinical routine since 2008; subsequently they were also approved for antepartum and subpartum procedures. The first study results have been published. Non-invasive foetal ECG is especially indicated during early pregnancy, while the Doppler CTG is recommended for the vernix period. Beyond the vernix period no difference has been recorded in the success rate of either approach. The foetal ECG signal quality is independent of the BMI, whereas the success rate of the Doppler CTG is diminished with an increased BMI. During the first stage of labour, non-invasive foetal ECG demonstrates better signal quality; however during the second stage of labour no difference has been identified between the methods.

Entities:  

Keywords:  Doppler CTG; fetal ECG; obstetrics

Year:  2012        PMID: 25308981      PMCID: PMC4168331          DOI: 10.1055/s-0031-1298329

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  14 in total

Review 1.  Fetal heart rate monitoring: is it salvageable?

Authors:  J T Parer; T King
Journal:  Am J Obstet Gynecol       Date:  2000-04       Impact factor: 8.661

2.  Cardiotocography only versus cardiotocography plus PR-interval analysis in intrapartum surveillance: a randomised, multicentre trial. FECG Study Group.

Authors:  B K Strachan; W J van Wijngaarden; D Sahota; A Chang; D K James
Journal:  Lancet       Date:  2000-02-05       Impact factor: 79.321

3.  Uterine activity monitoring during labour--a multi-centre, blinded two-way trial of external tocodynamometry against electrohysterography.

Authors:  J Reinhard; B R Hayes-Gill; S Schiermeier; H Löser; L M Niedballa; E Haarmann; A Sonnwald; W Hatzmann; T M Heinrich; F Louwen
Journal:  Z Geburtshilfe Neonatol       Date:  2011-10-25       Impact factor: 0.685

4.  Obesity in pregnancy: implications for the mother and lifelong health of the child. A consensus statement.

Authors:  Lucilla Poston; Lucien F Harthoorn; Eline M Van Der Beek
Journal:  Pediatr Res       Date:  2011-02       Impact factor: 3.756

5.  [The value of Doppler cardiotocogram computer analysis system 70 minutes before delivery].

Authors:  S Schiermeier; H Hatzmann; J Reinhard
Journal:  Z Geburtshilfe Neonatol       Date:  2008-10-27       Impact factor: 0.685

6.  Signal ambiguity resulting in unexpected outcome with external fetal heart rate monitoring.

Authors:  Duncan R Neilson; Roger K Freeman; Shelora Mangan
Journal:  Am J Obstet Gynecol       Date:  2008-04-02       Impact factor: 8.661

7.  Comparison of non-invasive fetal electrocardiogram to Doppler cardiotocogram during the 1st stage of labor.

Authors:  Joscha Reinhard; Barrie R Hayes-Gill; Qian Yi; Hendrike Hatzmann; Sven Schiermeier
Journal:  J Perinat Med       Date:  2010-03       Impact factor: 1.901

8.  Intrapartum heart rate ambiguity: a comparison of cardiotocogram and abdominal fetal electrocardiogram with maternal electrocardiogram.

Authors:  Joscha Reinhard; Barrie R Hayes-Gill; Sven Schiermeier; Hendrike Hatzmann; Tomas M Heinrich; Frank Louwen
Journal:  Gynecol Obstet Invest       Date:  2013-01-17       Impact factor: 2.031

Review 9.  Accuracy of frequency-related parameters of the electrohysterogram for predicting preterm delivery: a review of the literature.

Authors:  Maartje P G C Vinken; Chiara Rabotti; Massimo Mischi; S Guid Oei
Journal:  Obstet Gynecol Surv       Date:  2009-08       Impact factor: 2.347

10.  Sensitivity and specificity of intrapartum computerised FIGO criteria for cardiotocography and fetal scalp pH during labour: multicentre, observational study.

Authors:  S Schiermeier; S Pildner von Steinburg; A Thieme; J Reinhard; M Daumer; M Scholz; W Hatzmann; K T M Schneider
Journal:  BJOG       Date:  2008-08-25       Impact factor: 6.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.